Skip to content

HUMAN CORD BLOOD STEM CELL CONDITIONED MEDIA

40

Safety score · 0–100

Moderate

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

The growth medium from cultured human umbilical cord blood stem cells, containing haematopoietic stem cell secretions with broad bioactive potential.

Human cord blood stem cell conditioned media falls under EU Annex II/416 restriction for materials of human origin. Cord blood is a rich source of haematopoietic stem cells and is collected after birth with maternal consent. Sourcing is tightly regulated under blood and tissue establishment frameworks. The secretome includes haematopoietic growth factors, cytokines and potentially extracellular vesicles. The ingredient is considered ethically less problematic than embryonic sources but still requires significant safety documentation.

Skin benefits

  • Contains haematopoietic stem cell growth factors
  • Broad cytokine profile with potential immunomodulatory effects

Known concerns

  • EU Annex II/416 restriction
  • Maternal and infant consent required under blood establishment framework
  • Pathogen screening for blood-borne diseases mandatory
  • Undefined cord blood secretome

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Check your shelf

Find HUMAN CORD BLOOD STEM CELL CONDITIONED MEDIA in your products.

Scan any cosmetic product with LuxSense to see if it contains HUMAN CORD BLOOD STEM CELL CONDITIONED MEDIA and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.